CompoAtlas

OptiCleanse GHI Vanilla Delight

En vente sur le marché américain (selon le DSLD)

XYMOGEN, food supplement from the US market

OptiCleanse GHI Vanilla Delight (XYMOGEN), a food supplement au code-barres 722537511537, is described by its US market label. If sold in France, it would be subject to 8 points of French or European regulation, detailed below. Doses of folates, niacine, vitamine A are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
XYMOGEN
Barcode
722537511537
Form
Powder
One serving
57 g
Servings
up to 1 serving per day
Other ingredients (in English, as written)
dried Cane syrup, Sunflower Oil, Natural Flavors, Taurine, Glycine, Medium Chain Triglyceride Oil, Cellulose Gum, Xanthan Gum, L-Glutamine, Aminogen, Stevia Leaf Extract, Guar Gum, Silica
Ingredient (as written, in English)CategoryPer serving
CaloriesOther230 Calorie(s)
Total FatFat7 Gram(s)
Saturated FatFat1.5 Gram(s)
Total CarbohydratesCarbohydrate15 Gram(s)
Dietary FiberFibre3 Gram(s)
Total SugarsCarbohydrate5 Gram(s)
Added SugarsCarbohydrate5 Gram(s)
ProteinBlend26 Gram(s)
Vitamin AVitamin750 µg
Vitamin CVitamin250 mg
ThiamineVitamin15 mg
RiboflavinVitamin5 mg
NiacinVitamin40 mg
Vitamin B6Vitamin5 mg
FolateVitamin340 µg DFE (dietary folate equivalent)
Vitamin B12Vitamin50 µg
BiotinVitamin150 µg
Pantothenic AcidVitamin35 mg
CholineVitamin100 mg
CalciumMineral220 mg
IronMineral5 mg
IodineMineral60 µg
MagnesiumMineral140 mg
ZincMineral10 mg
SeleniumMineral100 µg
ManganeseMineral2 mg
ChromiumMineral60 µg
MolybdenumMineral35 µg
SodiumMineral560 mg
PotassiumMineral455 mg
stabilized Flaxseed (Linum usitatissimum)Plant5.6 Gram(s)
Alpha-Linolenic AcidFatty acid1.28 Gram(s)
Linoleic AcidFatty acid392 mg
Pomegranate Whole Fruit Extract (Punica granatum)Plant400 mg
Betaine AnhydrousOther substance250 mg
Lemon Bioflavonoid ComplexOther substance250 mg
QuercetinOther substance250 mg
PreventiumMineral250 mg
RutinOther substance200 mg
BCM-95 Turmeric extract (Curcuma longa)Plant200 mg
N-Acetyl-L-CysteineOther substance150 mg
GingerPlant150 mg
MethylsulfonylmethaneOther substance120 mg
Sodium Sulfate AnhydrousMineral100 mg
WatercressPlant100 mg
Green Tea aqueous extract (Camellia sinensis)Plant82 mg

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • stabilized Flaxseed
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

  • Pomegranate Whole Fruit Extract
    Read the warning, when it applies and the studies cited
  • Rutin
    Read the warning, when it applies and the studies cited

    RUTIN

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (PDR 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • BCM-95 Turmeric extract
    Read the warning, when it applies and the studies cited

    TURMERIC - CURCUMA LONGA - Oral

    Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 26 September 2025

    Turmeric -CURCUMA LONGA - Topical

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : XYMOGEN

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line